U.S. markets open in 8 hours 54 minutes
  • S&P Futures

    3,835.50
    +26.25 (+0.69%)
     
  • Dow Futures

    31,088.00
    +176.00 (+0.57%)
     
  • Nasdaq Futures

    13,053.50
    +142.50 (+1.10%)
     
  • Russell 2000 Futures

    2,229.90
    +30.70 (+1.40%)
     
  • Crude Oil

    62.49
    +0.99 (+1.61%)
     
  • Gold

    1,748.60
    +19.80 (+1.15%)
     
  • Silver

    26.97
    +0.52 (+1.99%)
     
  • EUR/USD

    1.2085
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.4600
    -1.5180 (-100.00%)
     
  • Vix

    27.95
    -28.89 (-100.00%)
     
  • GBP/USD

    1.3979
    +0.0056 (+0.40%)
     
  • USD/JPY

    106.5350
    +0.0330 (+0.03%)
     
  • BTC-USD

    46,278.56
    +1,330.80 (+2.96%)
     
  • CMC Crypto 200

    925.48
    -7.66 (-0.82%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    29,589.47
    +623.46 (+2.15%)
     

Is Now The Time To Look At Buying Codexis, Inc. (NASDAQ:CDXS)?

  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

While Codexis, Inc. (NASDAQ:CDXS) might not be the most widely known stock at the moment, it saw a significant share price rise of over 20% in the past couple of months on the NASDAQGS. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s examine Codexis’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

View our latest analysis for Codexis

What is Codexis worth?

According to my valuation model, Codexis seems to be fairly priced at around 1.3% below my intrinsic value, which means if you buy Codexis today, you’d be paying a reasonable price for it. And if you believe that the stock is really worth $26.64, then there isn’t much room for the share price grow beyond what it’s currently trading. Although, there may be an opportunity to buy in the future. This is because Codexis’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

Can we expect growth from Codexis?

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 71% over the next couple of years, the future seems bright for Codexis. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? It seems like the market has already priced in CDXS’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping an eye on CDXS, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

So while earnings quality is important, it's equally important to consider the risks facing Codexis at this point in time. For example - Codexis has 3 warning signs we think you should be aware of.

If you are no longer interested in Codexis, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.